Janus Henderson Group
FSTX

Janus Henderson Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Janus Henderson Group’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-522,158
Closed -$2.63M – 2729
2021
Q4 		$2.63M Sell
522,158
-156,233
-23% -$942K ﹤0.01% 1205
2021
Q3 		$4.93M Sell
678,391
-35,894
-5% -$246K ﹤0.01% 1059
2021
Q2 		$6.1M Buy
+714,285
New +$6.09M ﹤0.01% 1020

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group's FSTX Position: Q1 2022 in Review

Janus Henderson Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2022, closing a stake of 522,158 shares — an estimated $2.63M sold.

Janus Henderson Group first reported a position in FSTX in Q2 2021 and held it in 3 quarters. The position peaked at $6.1M in Q2 2021. 40 funds tracked by Wall St. Rank hold FSTX as of Q1 2022.

  • Janus Henderson Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Janus Henderson Group sold 522,158 F-star Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $2.63M.
  • Janus Henderson Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Janus Henderson Group's F-star Therapeutics, Inc. Common Stock position peaked at $6.1M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.